Literature DB >> 19343735

Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.

Itai Kela1, Alon Harmelin, Tova Waks, Avi Orr-Urtreger, Eytan Domany, Zelig Eshhar.   

Abstract

Prostate cancer (PC) is a heterogeneous disease whose aggressive phenotype is the second leading cause of cancer-related death in men. The identification of key molecules and pathways that play a pivotal role in PC progression towards an aggressive form is crucial. A major effort towards this end has been taken by global analyses of gene expression profiles. However, the large body of data did not provide a definitive idea about the genes which are associated with the aggressive growth of PC. In order to identify such genes, we performed an interspecies comparison between several human data sets and high quality microarray data that we generated from the transgenic adenocarcinoma of mouse prostate (TRAMP) strain. The TRAMP PC mimics the histological and pathological appearance as well as the aggressive phenotype of human PC (huPC). Analysis of the microarray data, derived from microdissected TRAMP specimens removed at different stages of the disease yielded genetic signatures delineating the TRAMP PC development and progression. Comparison of the TRAMP data with a set of genes representing the core expression signature of huPC yielded a limited set genes. Some of these genes are known predictors of poor prognosis in huPC. Interestingly, the modulation of genes responsible for the invasive phenotype of huPC occurs in TRAMP already during the transition to prostate intraepithelial neoplasia (PIN) and onwards to localized tumors. We therefore suggest that critical oncogenic events leading to an aggressive phenotype of huPC can be studied in the PIN stage of TRAMP. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343735     DOI: 10.1002/pros.20950

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Dietary Tomato or Lycopene Do Not Reduce Castration-Resistant Prostate Cancer Progression in a Murine Model.

Authors:  Joe L Rowles; Joshua W Smith; Catherine C Applegate; Rita J Miller; Matthew A Wallig; Amandeep Kaur; Jesus N Sarol; Salma Musaad; Steven K Clinton; William D O'Brien; John W Erdman
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

2.  Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis.

Authors:  Lei Wan; Hsueh-Li Tan; Jennifer M Thomas-Ahner; Dennis K Pearl; John W Erdman; Nancy E Moran; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-14

3.  Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.

Authors:  Stefania Mazzoleni; Elena Jachetti; Sara Morosini; Matteo Grioni; Ignazio Stefano Piras; Mauro Pala; Alessandro Bulfone; Massimo Freschi; Matteo Bellone; Rossella Galli
Journal:  Stem Cells Transl Med       Date:  2013-07-24       Impact factor: 6.940

4.  Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations.

Authors:  Junxuan Lü; Jinhui Zhang; Li Li; Cheng Jiang; Chengguo Xing
Journal:  Curr Pharmacol Rep       Date:  2015-04-19

5.  PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.

Authors:  Sheng Yao; Alix Bee; Daniel Brewer; Andrew Dodson; Carol Beesley; Youqiang Ke; Laurence Ambroisine; Gabrielle Fisher; Heinrich Møller; Tim Dickinson; Patricia Gerard; Lu-Yu Lian; Janet Risk; Brian Lane; Paul Smith; Victor Reuter; Daniel Berney; Christine Gosden; Peter Scardino; Jack Cuzick; Mustafa B A Djamgoz; Colin Cooper; Christopher S Foster
Journal:  Genes Cancer       Date:  2010-05

6.  Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.

Authors:  Min Zou; Roxanne Toivanen; Antonina Mitrofanova; Nicolas Floch; Sheida Hayati; Yanping Sun; Clémentine Le Magnen; Daniel Chester; Elahe A Mostaghel; Andrea Califano; Mark A Rubin; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Discov       Date:  2017-04-14       Impact factor: 39.397

7.  Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.

Authors:  Alfonso Calvo; Carlos Perez-Stable; Victor Segura; Raúl Catena; Elizabeth Guruceaga; Paul Nguewa; David Blanco; Luis Parada; Teresita Reiner; Jeffrey E Green
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

8.  Stage-specific regulation of Solanum lycopersicum leaf maturation by class 1 KNOTTED1-LIKE HOMEOBOX proteins.

Authors:  Eilon Shani; Yogev Burko; Lilach Ben-Yaakov; Yael Berger; Ziva Amsellem; Alexander Goldshmidt; Eran Sharon; Naomi Ori
Journal:  Plant Cell       Date:  2009-10-09       Impact factor: 11.277

9.  Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.

Authors:  Jinhui Zhang; Lei Wang; Yong Zhang; Li Li; Suni Tang; Chengguo Xing; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Mol Carcinog       Date:  2014-10-12       Impact factor: 4.784

10.  Endosomal gene expression: a new indicator for prostate cancer patient prognosis?

Authors:  Ian R D Johnson; Emma J Parkinson-Lawrence; Helen Keegan; Cathy D Spillane; Jacqui Barry-O'Crowley; William R Watson; Stavros Selemidis; Lisa M Butler; John J O'Leary; Doug A Brooks
Journal:  Oncotarget       Date:  2015-11-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.